Chalazia Development in Multiple Myeloma: A New Complication Associated with Bortezomib Therapy
Abstract
Share and Cite
Yun, C.; Mukhi, N.; Kremer, V.; Shinder, R.; Verma, V.; Batuman, O. Chalazia Development in Multiple Myeloma: A New Complication Associated with Bortezomib Therapy. Hematol. Rep. 2015, 7, 5729. https://doi.org/10.4081/hr.2015.5729
Yun C, Mukhi N, Kremer V, Shinder R, Verma V, Batuman O. Chalazia Development in Multiple Myeloma: A New Complication Associated with Bortezomib Therapy. Hematology Reports. 2015; 7(2):5729. https://doi.org/10.4081/hr.2015.5729
Chicago/Turabian StyleYun, Charles, Nikhil Mukhi, Valerie Kremer, Roman Shinder, Vaibhav Verma, and Olcay Batuman. 2015. "Chalazia Development in Multiple Myeloma: A New Complication Associated with Bortezomib Therapy" Hematology Reports 7, no. 2: 5729. https://doi.org/10.4081/hr.2015.5729